Social Media Use in Adolescents Admitted to a Psychiatric Unit

January 6, 2022 updated by: Kaiser Permanente
We will investigate the association between social media use and depression in adolescents admitted to a psychiatric unit and continue to follow their progress after discharge in outpatient clinic services. We expect improvement in their depressive symptoms by modifying social media use and adding a mental health app to further encourage the positive effects of social media.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • Chino, California, United States, 91710
        • Canyon Ridge Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participants admitted to inpatient psychiatric unit
  • Kaiser insured participants between 13-17 years of age with parental consent
  • positive for social media use
  • English speaking

Exclusion Criteria:

  • pregnant
  • non English speaking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Treatment As Usual
Standard of care as usual with follow-up at 1-, 3-, and 6-months
Behavioral: Treatment as usual
TAU as per standard of care
Active Comparator: Intervention with CBT Mobile App
Treatment as usual with additional treatment using cognitive behavioral therapy (CBT) mobile apps (ie What's Up?)
Behavioral: CBT Mobile App
TAU and the additional treatment of a Mental Health App (What's Up?). This app will be used to guide adolescents through cognitive behavioral therapy and acceptance commitment therapy techniques, as well as to assist in developing coping mechanisms to prevent readmission.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparing depression scale,PHQ9-A (Patient Health Questionnaire, Adolescent Version), with social media use
Time Frame: 1 month
Compare presence and severity of depressive symptoms in treatment as usual (TAU) group with TAU and the mobile app intervention group. The presence and severity of depression will be determined using the PHQ9-A (Patient Health Questionnaire, adolescent version), a 9-question depression scale that is based on the DSM-IV diagnostic criteria of depression and modified for teens to further inquire about other aspects of depression such as dysthymia, suicide risk, and other mental illnesses. The PHQ-9A scores each of the DSM-IV criteria as "0" (not at all) to "3" (nearly every day). Total depression severity score ranges of 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.
1 month
Comparing depression scale,PHQ9-A (Patient Health Questionnaire, Adolescent Version), with social media use
Time Frame: 3 months
Compare presence and severity of depressive symptoms in treatment as usual (TAU) group with TAU and the mobile app intervention group. The presence and severity of depression will be determined using the PHQ9-A (Patient Health Questionnaire, adolescent version), a 9-question depression scale that is based on the DSM-IV diagnostic criteria of depression and modified for teens to further inquire about other aspects of depression such as dysthymia, suicide risk, and other mental illnesses. The PHQ-9A scores each of the DSM-IV criteria as "0" (not at all) to "3" (nearly every day). Total depression severity score ranges of 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.
3 months
Comparing depression scale,PHQ9-A (Patient Health Questionnaire, Adolescent Version), with social media use
Time Frame: 6 months
Compare presence and severity of depressive symptoms in treatment as usual (TAU) group with TAU and the mobile app intervention group. The presence and severity of depression will be determined using the PHQ9-A (Patient Health Questionnaire, adolescent version), a 9-question depression scale that is based on the DSM-IV diagnostic criteria of depression and modified for teens to further inquire about other aspects of depression such as dysthymia, suicide risk, and other mental illnesses. The PHQ-9A scores each of the DSM-IV criteria as "0" (not at all) to "3" (nearly every day). Total depression severity score ranges of 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kaiser Permanente

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 1, 2019

Primary Completion (Anticipated)

October 31, 2020

Study Completion (Anticipated)

October 31, 2021

Study Registration Dates

First Submitted

February 8, 2019

First Submitted That Met QC Criteria

February 8, 2019

First Posted (Actual)

February 11, 2019

Study Record Updates

Last Update Posted (Actual)

January 18, 2022

Last Update Submitted That Met QC Criteria

January 6, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 029021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

All data will be collected by trained study personnel, and each study participant will be assigned a unique study number. Data will be de-identified after collection and hard copies of data will be stored in a locked cabinet in the investigator's office. We are considering options to share de-identified data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Treatment as usual

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe